Dena Zeraatkar

You all. I found a beautiful study to write about @Sensible__Med. A new way to analyze observational studies. Gosh, I am excited. Not only to find this study but also to talk with senior author @DenaZera Post here sensible-med.com/p/the-definiti… Podcast tomorrow.

x.com/i/article/2030…

🚨 Excited to share our new paper in @LancetRespirMed 🚨 Our systematic review & network meta-analysis compares preoxygenation strategies for critically ill patients needing intubation. NIPPV tops HFNC & facemask in reducing hypoxaemia. 🔍 Study Highlights • Systematic review & network meta-analysis of 15 RCTs (n=3420) • Compared HFNC, NIPPV, and facemask oxygen for preoxygenation • NIPPV likely best at reducing hypoxaemia during intubation   – vs HFNC: RR 0.73 (moderate certainty)   – vs facemask: RR 0.51 (high certainty) • HFNC better than facemask: RR 0.69 (high certainty) • No strategy improved first-attempt intubation success • NIPPV may reduce serious adverse events vs HFNC/facemask • No clear mortality difference between methods • Data used to inform upcoming international airway guidelines 🧠 Implications: NIPPV may be preferred in high-risk or critically ill patients; findings support evidence-based guideline updates kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… @UofT_DoM @MacDeptMed @Bram_Rochwerg @DenaZera @HEI_mcmaster

Led by researchers at @McMasterU, a new study suggests that rehabilitation and talk therapies can help reduce long Covid symptoms and that “no compelling evidence supported the effectiveness” of other treatments, including certain drugs or oxygen therapy. ow.ly/jg2a50UhHyL